Maximising The Potential Of PCR As A Diagnostic Tool
Email alerts
Free registration
Chat area
Certificate of attendance
The past year has seen an exponential increase in Polymerase Chain Reaction (PCR) and Real-Time Polymerase Chain Reaction (RT-PCR) testing like never before due to it being the 'gold standard' test to detect SARS-CoV-2 during the pandemic. PCR is used for its high sensitivity and simplicity which enables it to identify bacteria, viruses and detect early infection in many chronic diseases.
As a pioneer in clinical diagnostics, Novacyt has a proven history of responding quickly to changing global health needs, including providing testing solutions for Zika, swine flu and Ebola viruses. Solidifying this position, Novacyt were among the first to respond to the COVID-19 pandemic in 2020, providing a rapid and reliable CE-IVD marked SARS-CoV-2 assay kit. Whatever testing you are conducting, join us as we discuss how you can make your PCR more effective! We will look at ways of improving the clinical sensitivity of the workflow, understanding limits of clinical performance data and ensuring the right controls are used during tests!
For more information, please contact us at webinar@avantorsciences.com
Presented by
Dr. Paul Oladimeji
Dr. Paul Oladimeji is the Director of Product Development at Novacyt, responsible for Primer Design’s research and development activities. He specialises in PCR technologies which makes him very effective at providing regulatory, operational and strategic support in his role. His earlier work includes a strong focus on investigating molecular pathway disturbances in major psychiatric disorders such as schizophrenia.